• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第二部分

Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part II.

作者信息

Viaggi Bruno, Cangialosi Alice, Langer Martin, Olivieri Carlo, Gori Andrea, Corona Alberto, Finazzi Stefano, Di Paolo Antonello

机构信息

Department of Anesthesiology, Neuro-Intensive Care Unit, Careggi University Hospital, 50139 Florence, Italy.

Associazione GiViTI, c/o Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.

出版信息

Antibiotics (Basel). 2022 Sep 3;11(9):1193. doi: 10.3390/antibiotics11091193.

DOI:10.3390/antibiotics11091193
PMID:36139972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9495066/
Abstract

In patients that are admitted to intensive care units (ICUs), the clinical outcome of severe infections depends on several factors, as well as the early administration of chemotherapies and comorbidities. Antimicrobials may be used in off-label regimens to maximize the probability of therapeutic concentrations within infected tissues and to prevent the selection of resistant clones. Interestingly, the literature clearly shows that the rate of tissue penetration is variable among antibacterial drugs, and the correlation between plasma and tissue concentrations may be inconstant. The present review harvests data about tissue penetration of antibacterial drugs in ICU patients, limiting the search to those drugs that mainly act as protein synthesis inhibitors and disrupting DNA structure and function. As expected, fluoroquinolones, macrolides, linezolid, and tigecycline have an excellent diffusion into epithelial lining fluid. That high penetration is fundamental for the therapy of ventilator and healthcare-associated pneumonia. Some drugs also display a high penetration rate within cerebrospinal fluid, while other agents diffuse into the skin and soft tissues. Further studies are needed to improve our knowledge about drug tissue penetration, especially in the presence of factors that may affect drug pharmacokinetics.

摘要

在入住重症监护病房(ICU)的患者中,严重感染的临床结局取决于多种因素,以及化疗的早期应用和合并症。抗菌药物可能会用于超说明书用药方案,以最大限度地提高感染组织内达到治疗浓度的概率,并防止耐药克隆的产生。有趣的是,文献清楚地表明,抗菌药物的组织穿透率各不相同,血浆浓度与组织浓度之间的相关性可能并不恒定。本综述收集了关于ICU患者抗菌药物组织穿透情况的数据,将检索范围限制在主要作为蛋白质合成抑制剂以及破坏DNA结构和功能的药物。不出所料,氟喹诺酮类、大环内酯类、利奈唑胺和替加环素在上皮衬液中具有良好的扩散性。这种高穿透性对于呼吸机相关性肺炎和医疗保健相关肺炎的治疗至关重要。一些药物在脑脊液中的穿透率也很高,而其他药物则可扩散到皮肤和软组织中。需要进一步研究以增进我们对药物组织穿透的了解,尤其是在存在可能影响药物药代动力学的因素的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/9495066/eb8aa4ff56e4/antibiotics-11-01193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/9495066/eb8aa4ff56e4/antibiotics-11-01193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2415/9495066/eb8aa4ff56e4/antibiotics-11-01193-g001.jpg

相似文献

1
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part II.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第二部分
Antibiotics (Basel). 2022 Sep 3;11(9):1193. doi: 10.3390/antibiotics11091193.
2
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第一部分
Antibiotics (Basel). 2022 Aug 29;11(9):1164. doi: 10.3390/antibiotics11091164.
3
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.利奈唑胺用于治疗呼吸机相关性肺炎重症患者的药代动力学及肺内浓度
Crit Care Med. 2005 Jul;33(7):1529-33. doi: 10.1097/01.ccm.0000168206.59873.80.
4
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.组织穿透性在实现耐甲氧西林金黄色葡萄球菌引起的医院获得性肺炎和复杂性皮肤软组织感染的成功抗菌治疗中的重要性:万古霉素和利奈唑胺。
Curr Med Res Opin. 2010 Mar;26(3):571-88. doi: 10.1185/03007990903512057.
5
Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.抗菌药物在儿童和青少年脑脊液中的药代动力学。
Paediatr Drugs. 2013 Apr;15(2):93-117. doi: 10.1007/s40272-013-0017-5.
6
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.重症监护病房患者上消化道出血的预防干预措施。
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2.
7
Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update.抗菌药物向肺部上皮衬液中的渗透:更新。
Clin Pharmacokinet. 2022 Jan;61(1):17-46. doi: 10.1007/s40262-021-01061-7. Epub 2021 Oct 15.
8
Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs.替加环素在感染和未感染小鼠肺部上皮衬液中的渗透比较。
J Antimicrob Chemother. 2009 Oct;64(4):837-9. doi: 10.1093/jac/dkp301. Epub 2009 Aug 19.
9
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.欧洲视角:利奈唑胺治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎 10 余年的经验总结与更新
Clin Microbiol Infect. 2014 Apr;20 Suppl 4:19-36. doi: 10.1111/1469-0691.12450.
10
The glycylcyclines: a comparative review with the tetracyclines.甘氨酰环素类:与四环素类的比较性综述
Drugs. 2004;64(1):63-88. doi: 10.2165/00003495-200464010-00005.

引用本文的文献

1
Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice.基因工程改造的间充质基质/干细胞作为抗菌肽LL-37类似物SE-33的递送平台:C57BL/6小鼠的临床前药代动力学和组织分布
Antibiotics (Basel). 2025 Apr 24;14(5):429. doi: 10.3390/antibiotics14050429.
2
Fluoroquinolones and Biofilm: A Narrative Review.氟喹诺酮类药物与生物膜:一篇叙述性综述。
Pharmaceuticals (Basel). 2024 Dec 11;17(12):1673. doi: 10.3390/ph17121673.
3
Impact of vancomycin therapeutic drug monitoring on mortality in sepsis patients across different age groups: a propensity score-matched retrospective cohort study.

本文引用的文献

1
Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.提高对克林霉素药理学和药代动力学的认识以适应实际应用的方法。
Antibiotics (Basel). 2022 May 21;11(5):701. doi: 10.3390/antibiotics11050701.
2
Detection of carbapenemases bla-bla-bla-bla and extended-spectrum-β-lactamase bla-bla-bla genes in Gram-negative bacterial isolates from ICU burns patients.检测 ICU 烧伤患者革兰氏阴性细菌分离株中的 bla-bla-bla-bla 碳青霉烯酶基因和 bla-bla-bla-bla 扩展谱β-内酰胺酶基因。
Ann Clin Microbiol Antimicrob. 2022 May 19;21(1):18. doi: 10.1186/s12941-022-00510-w.
3
Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
万古霉素治疗药物监测对不同年龄组脓毒症患者死亡率的影响:一项倾向评分匹配的回顾性队列研究
Front Med (Lausanne). 2024 Dec 12;11:1498337. doi: 10.3389/fmed.2024.1498337. eCollection 2024.
4
The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.危重症患者炎症生物标志物与药物药代动力学的关系:范围综述。
Crit Care. 2024 Nov 19;28(1):376. doi: 10.1186/s13054-024-05150-4.
5
Clinical Pharmacist Involved in the Treatment of Pneumonia: A Case Report.临床药师参与肺炎治疗:一例报告
Infect Drug Resist. 2024 Nov 11;17:5001-5010. doi: 10.2147/IDR.S477404. eCollection 2024.
6
Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study.用于椎间盘给药的利奈唑胺制剂PP353在慢性腰痛伴Modic 1型改变患者中的药代动力学:一项首次人体、1b期、开放标签、单剂量研究。
JOR Spine. 2024 Nov 14;7(4):e70009. doi: 10.1002/jsp2.70009. eCollection 2024 Dec.
7
Genetic Testing Technology Assisting in the Diagnosis and Treatment of Multiple Suppurative Arthritis and Extensive Migratory Skin and Soft Tissue Infections Caused by Disseminated Staphylococcus aureus Disease: A Case Report and Review.基因检测技术辅助诊断和治疗播散性金黄色葡萄球菌病引起的多发性化脓性关节炎及广泛性游走性皮肤和软组织感染:1例报告及文献复习
Infect Drug Resist. 2024 Sep 25;17:4185-4194. doi: 10.2147/IDR.S479043. eCollection 2024.
8
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review.了解重症患者的抗菌药物药代动力学以优化抗菌治疗:一篇叙述性综述。
J Intensive Med. 2024 Feb 29;4(3):287-298. doi: 10.1016/j.jointm.2023.12.007. eCollection 2024 Jul.
9
Molecular epidemiology and clinical significance of carbapenemase genes in carbapenem-resistant Acinetobacter baumannii isolates in southern Poland.波兰南部碳青霉烯类耐药鲍曼不动杆菌分离株中产碳青霉烯酶基因的分子流行病学及临床意义。
Pol Arch Intern Med. 2024 Jun 27;134(6). doi: 10.20452/pamw.16734. Epub 2024 Apr 23.
10
Co-Administration of High-Dose Nebulized Colistin for Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes.大剂量雾化多黏菌素联合治疗菌血症性呼吸机相关性肺炎:对预后的影响。
Antibiotics (Basel). 2024 Feb 8;13(2):169. doi: 10.3390/antibiotics13020169.
接受体外膜肺氧合(ASAP ECMO 研究)的危重症患者中环丙沙星的群体药代动力学。
Anaesth Crit Care Pain Med. 2022 Jun;41(3):101080. doi: 10.1016/j.accpm.2022.101080. Epub 2022 Apr 25.
4
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients.连续输注利奈唑胺在危重症患者中的群体药代动力学和毒代动力学。
Int J Antimicrob Agents. 2022 May;59(5):106572. doi: 10.1016/j.ijantimicag.2022.106572. Epub 2022 Mar 18.
5
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.个体化抗生素药代动力学和药效学在危重症患者中的应用。
Anaesth Crit Care Pain Med. 2021 Dec;40(6):100970. doi: 10.1016/j.accpm.2021.100970. Epub 2021 Oct 30.
6
Dose optimisation based on pharmacokinetic/pharmacodynamic target of tigecycline.基于替加环素药代动力学/药效学目标的剂量优化。
J Glob Antimicrob Resist. 2021 Jun;25:315-322. doi: 10.1016/j.jgar.2021.04.006. Epub 2021 May 4.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
Nosocomial Infection.医院感染。
Crit Care Med. 2021 Feb 1;49(2):169-187. doi: 10.1097/CCM.0000000000004783.
9
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.药物暴露和最小抑菌浓度可预测肺结核治疗反应。
Clin Infect Dis. 2021 Nov 2;73(9):e3520-e3528. doi: 10.1093/cid/ciaa1569.
10
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.